VOLITIONRX LTD
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
VNRX$0.18-7.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Deficit
Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited)
| For the Nine Months Ended September 30, 2024 and September 30, 2023 | |||||||
|---|---|---|---|---|---|---|---|
| Accumulated | |||||||
| Additional · Other · Non - | |||||||
| Common Stock · Paid-in · Comprehensive · Accumulated · Controlling | |||||||
| Shares | Amount | Capital | Income | Deficit | Interest | Total | |
| # | $ | $ | $ | $ | $ | $ | |
| Balance, December 31, 2023 | 81,898,321 | 81,898 | 194,448,414 | 243,940 | (202,576,507) | (909,967) | (8,712,222) |
| Common stock issued for cash, net of issuance costs | 13,350 | 13 | 15,721 | - | - | - | 15,734 |
| Common stock issued for settlement of RSUs | 68,169 | 69 | (69) | - | - | - | - |
| Common stock issued in lieu of license fee | 129,132 | 129 | 125,129 | - | - | - | 125,258 |
| Stock-based compensation | - | - | 411,220 | - | - | - | 411,220 |
| Tax withholdings paid related to stock-based compensation | - | - | (3,062) | - | - | - | (3,062) |
| Foreign currency translation | - | - | - | 15,026 | - | - | 15,026 |
| Net loss for the period | - | - | - | - | (8,367,388) | (104,617) | (8,472,005) |
| Balance, March 31, 2024 | 82,108,972 | 82,109 | 194,997,353 | 258,966 | (210,943,895) | (1,014,584) | (16,620,051) |
| Common stock issued for cash, net of issuance costs | 734,155 | 734 | 588,754 | - | - | - | 589,488 |
| Common stock issued for settlement of RSUs | 85,187 | 85 | (85) | - | - | - | - |
| Stock-based compensation | - | - | 208,046 | - | - | - | 208,046 |
| Tax withholdings paid related to stock-based compensation | - | - | (38,205) | - | - | - | (38,205) |
| Foreign currency translation | - | - | - | 23,286 | - | - | 23,286 |
| Net loss for the period | - | - | - | - | (6,985,546) | (74,629) | (7,060,175) |
| Balance, June 30, 2024 | 82,928,314 | 82,928 | 195,755,863 | 282,252 | (217,929,441) | (1,089,213) | (22,897,611) |
| Common stock issued for cash, net of issuance costs | 9,170,000 | 9,170 | 5,951,030 | - | - | - | 5,960,200 |
| Common stock issued for settlement of RSUs | 294,256 | 295 | (295) | - | - | - | - |
| Stock-based compensation | - | - | 323,539 | - | - | - | 323,539 |
| Tax withholdings paid related to stock-based compensation | - | - | (15,860) | - | - | - | (15,860) |
| Foreign currency translation | - | - | (141,980) | - | - | (141,980) | |
| Net loss for the period | - | - | - | (5,821,529) | (47,049) | (5,868,578) | |
| Balance, September 30, 2024 | 92,392,570 | 92,393 | 202,014,277 | 140,272 | (223,750,970) | (1,136,262) | (22,640,290) |
| (The accompanying notes are an integral part of these condensed consolidated financial statements) | |||||||
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)
| Accumulated | |||||||
|---|---|---|---|---|---|---|---|
| Additional · Other · Non - | |||||||
| Common Stock · Paid-in · Comprehensive · Accumulated · Controlling | |||||||
| Shares | Amount | Capital | Income (Loss) | Deficit | Interest | Total | |
| # | $ | $ | $ | $ | $ | $ | |
| Balance, December 31, 2022 | 57,873,379 | 57,873 | 164,397,468 | 227,097 | (167,257,429) | (551,971) | (3,126,962) |
| Common stock issued for cash, net of issuance costs | 5,225,703 | 5,225 | 8,422,430 | - | - | - | 8,427,655 |
| Common stock issued for settlement of RSUs | 26,978 | 27 | (27) | - | - | - | - |
| Stock-based compensation | - | - | 693,657 | - | - | - | 693,657 |
| Tax withholdings paid related to stock-based compensation | - | - | (14,336) | - | - | - | (14,336) |
| Common stock repurchased | (13,294) | (13) | (31,759) | - | - | - | (31,772) |
| Foreign currency translation | - | - | - | (56,478) | - | - | (56,478) |
| Net loss for the period | - | - | - | - | (8,779,548) | (93,361) | (8,872,909) |
| Balance, March 31, 2023 | 63,112,766 | 63,112 | 173,467,433 | 170,619 | (176,036,977) | (645,332) | (2,981,145) |
| Common stock issued for cash, net of issuance costs | 14,950,000 | 14,950 | 17,071,656 | - | - | - | 17,086,606 |
| Common stock issued for settlement of RSUs | 74,598 | 75 | (75) | - | - | - | - |
| Stock-based compensation | - | - | 592,174 | - | - | - | 592,174 |
| Tax withholdings paid related to stock-based compensation | - | - | (65,895) | - | - | - | (65,895) |
| Foreign currency translation | - | - | - | 37,712 | - | - | 37,712 |
| Net loss for the period | - | - | - | - | (9,470,979) | (80,298) | (9,551,277) |
| Balance, June 30, 2023 | 78,137,364 | 78,137 | 191,065,293 | 208,331 | (185,507,956) | (725,630) | 5,118,175 |
| Issuance costs | - | - | (12,501) | - | - | - | (12,501) |
| Common stock issued for settlement of RSUs | 206,053 | 206 | (206) | - | - | - | - |
| Stock-based compensation | - | - | 537,980 | - | - | - | 537,980 |
| Tax withholdings paid related to stock-based compensation | - | - | (73,066) | - | - | - | (73,066) |
| Foreign currency translation | - | - | - | 31,291 | - | - | 31,291 |
| Net loss for the period | - | - | - | - | (8,370,301) | (82,887) | (8,453,188) |
| Balance, September 30, 2023 | 78,343,417 | 78,343 | 191,517,500 | 239,622 | (193,878,257) | (808,517) | (2,851,309) |
| (The accompanying notes are an integral part of these condensed consolidated financial statements) | |||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.